Results 51 to 60 of about 1,018 (169)

Comparison of the clinical characteristics of TAFRO syndrome and idiopathic multicentric Castleman disease in general internal medicine: a 6‐year retrospective study [PDF]

, 2019
Background Although thrombocytopenia, anasarca, fever, reticulin fibrosis and organomegaly (TAFRO) syndrome was first described as a variant of idiopathic multicentric Castleman disease (CD), patients with TAFRO syndrome demonstrate more aggressive ...
Fujii, Nobuharu, Hanayama, Yoshihisa, Kondo, Eisei, Nishimura, Yoshito, Otsuka, Fumio   +4 more
core   +1 more source

TAFRO syndrome as a cause of glomerular microangiopathy: a case report and literature review

BMC Nephrology, 2019
Background TAFRO syndrome is a systemic inflammatory disorder that manifests as thrombocytopenia (T), anasarca (A), fever (F), reticulin fibrosis (R), and organomegaly (O).
Yoshikuni Nagayama, Mizuki Yamano, Motoka Yagame, Tomoyuki Nariyama, Mikiko Takahashi, Masashi Kawamoto, Katsuyuki Matsui   +6 more
doaj   +1 more source

Intracranial Hemorrhage in a Patient with TAFRO Syndrome Treated with Cyclosporine A and Rituximab

Medicina, 2021
TAFRO syndrome, a rare subtype of idiopathic multicentric Castleman disease, manifests as thrombocytopenia, anasarca, fever, reticulin fibrosis, and organomegaly. Thrombotic microangiopathy, including renal dysfunction, is frequently associated with this
Yuina Akagi, Takashi Kato, Yusuke Yamashita, Hiroki Hosoi, Shogo Murata, Shuto Yamamoto, Kenji Warigaya, Taisei Nakao, Shinichi Murata, Takashi Sonoki, Shinobu Tamura   +10 more
doaj   +1 more source

TAFRO syndrome with primary Sjogren's syndrome

Japanese Journal of Clinical Immunology, 2016
A 25-year-old woman diagnosed 1 year earlier with Primary Sjogren's syndrome was admitted to a nearby hospital with fever of unknown origin. Examination revealed anasarca, systemic lymphadenopathy, hepatosplenomegaly and high C-reactive protein level.
Nozomi, Iwanaga, Kohei, Harada, Yoshika, Tsuji, Chieko, Kawahara, Kazuhiro, Kurohama, Yasumori, Izumi, Shinichiro, Yoshida, Keita, Fujikawa, Masahiro, Ito, Atsushi, Kawakami, Kiyoshi, Migita   +10 more
openaire   +3 more sources

Subclinical Hypothyroidism in TAFRO Syndrome

Internal Medicine, 2019
Objective TAFRO syndrome is rare, and its underlying mechanisms currently remain unknown. Furthermore, standard therapeutic strategies have yet to be established. One of the hallmarks of TAFRO is pathological hypercytokinemia, which involves vascular endothelial growth factor (VEGF).
Oka, Satoko, Ono, Kazuo, Nohgawa, Masaharu   +2 more
openaire   +3 more sources

Severe refractory TAFRO syndrome requiring continuous renal replacement therapy complicated with Trichosporon asahii infection in the lungs and myocardial infarction: an autopsy case report and literature review

Renal Replacement Therapy, 2018
Background TAFRO (thrombocytopenia, anasarca, fever, reticulin myelofibrosis/renal failure, and organomegaly) syndrome is a systemic inflammatory disorder and unique clinicopathological variant of idiopathic multicentric Castleman disease that was ...
Arata Hibi, Ken Mizuguchi, Akiko Yoneyama, Takahisa Kasugai, Keisuke Kamiya, Keisuke Kamiya, Chiharu Ito, Satoru Kominato, Toshiyuki Miura, Katsushi Koyama   +9 more
doaj   +1 more source

TAFRO Syndrome and Elusive Diagnosis of Idiopathic Multicentric Castleman Disease Treated with Empiric Anti-Interleukin-6 Therapy

Case Reports in Oncology, 2021
TAFRO syndrome is defined by the presence of thrombocytopenia (T), anasarca (A), fever (F), reticulin fibrosis/renal dysfunction (R), and organomegaly (O) and can be seen with idiopathic multicentric Castleman disease (iMCD) or as an isolated process ...
Corinne Williams, Alexis Phillips, Vikram Aggarwal, Liron Barnea Slonim, David C. Fajgenbaum, Reem Karmali   +5 more
doaj   +1 more source

Acute Kidney Injury Caused by TAFRO Syndrome in a Chinese Patient: Efficacy of Long-Term Corticosteroids Combined with Bortezomib and Cyclophosphamide

Kidney & Blood Pressure Research, 2020
Introduction: Thrombocytopenia, ascites, myelofibrosis, renal dysfunction, and organomegaly (TAFRO) syndrome is a newly recognized and rare clinical subtype of Castleman disease. Renal involvement in TAFRO syndrome usually presents with mild proteinuria,
Peng Xia, Lu Zhang, Menglian Zou, Tengyue Zhang, Ran Li, Xiaoxiao Shi, Jing Wang, Yan Qin, Xuemei Li, Jian Li, Limeng Chen   +10 more
doaj   +1 more source

A severe case of thrombocytopenia, anasarca, fever, renal insufficiency or reticulin fibrosis, and organomegaly syndrome with myocardial and skeletal muscle calcification despite hypocalcemia: a case report

Journal of Medical Case Reports, 2021
Background TAFRO (thrombocytopenia, anasarca, fever, renal insufficiency or reticulin fibrosis, and organomegaly) syndrome is a recently recognized disease with a variety of presentations of variable severity.
Shogo Minomo, Yu Fujiwara, Shota Sakashita, Akito Takamura, Kaoru Nagata   +4 more
doaj   +1 more source

Idiopathic multicentric Castleman disease: pathogenesis, clinical presentation and recommendations for treatment based on the Castleman Disease Collaborative Network (CDCN) [PDF]

, 2021
Castleman disease is a very rare, lymphoproliferative disease, driven by dysregulation of the cytokine interleukin 6 (IL-6) and other proinflammatory cytokines with the development of symptoms of systemic inflammation, reactive proliferation of ...
Domańska-Czyż, Katarzyna, Ostrowska, Beata, Romejko-Jarosińska, Joanna, Walewski, Jan   +3 more
core   +2 more sources